thoracic aortic aneurysm, thoracic aortic dissection
Conditions
Interventions
Group treated with the hydrochloride salt landiolol
Group treated without the hydrochloride salt landiolol
Sponsors
Hiroshima University Institute of Biomedical and Health Sciences Applied Life Sciences Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (a) Age at the time of obtaining informed consent of patients aged 20 years or older (b) Patients scheduled for thoracic aortic aneurysm or dissection underwent replacement surgery. (c)Patient consent is obtained in writing with respect to participation in the study
Exclusion criteria
Exclusion criteria: Corresponding to patient contraindications hydrochloride landiolol Patients with acute myocardial infarction within 3 days. Patients with supraventricular arrhythmia that might need treatment. Patients with severe heart failure (NYHA III degrees or more just before surgery, EF less than 35%). Patients with atrial fibrillation cause of electrolyte abnormalities, WPW syndrome and hyperthyroidism. Diastolic blood pressure / systolic patients less than 90/60 mmHg. Patients with severe asthma. Patients who take an oral antiarrhythmic drugs or beta blocker. Patients who were found to be inappropriate physician to carry out the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients with atrial fibrillation coarse-until 7 days after surgery occurred. | — |
Countries
Japan
Contacts
Public ContactKeisuke Watadani
Hiroshima University Institute of Biomedical and Health Sciences Applied Life Sciences Surgery
Outcome results
None listed